Načítá se...
Evaluating somatic tumor mutation detection without matched normal samples
BACKGROUND: Observations of recurrent somatic mutations in tumors have led to identification and definition of signaling and other pathways that are important for cancer progression and therapeutic targeting. As tumor cells contain both an individual’s inherited genetic variants and somatic mutation...
Uloženo v:
| Vydáno v: | Hum Genomics |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5584341/ https://ncbi.nlm.nih.gov/pubmed/28870239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40246-017-0118-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|